www.astro.org
Abstract # 2201 Baseline Albumin/Bilirubin Ratio (ABR) as a Predictor of Yttrium-90 Microsphere (TheraSphere) Treatment Outcome

Presenter: Kelly, Douglas

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
Dr. Doug Kelly is a radiation oncologist at Cancer Treatment Centers of America in Tulsa, OK.

Authors:
D. A. Kelly, F. Brunk, A. Sen, J. P. Flynn, M. West, A. Movahed, F. Pascual, Cancer Treatment Centers of America, Tulsa, OK

Author Disclosure:
 D.A. Kelly, None; F. Brunk, None; A. Sen, None; J.P. Flynn, None; M. West, None; A. Movahed, None; F. Pascual, None.

Click on images to enlarge (a new pop-up window will open)

Entire Poster:



E-mail a friend about this abstract:
Enter email address: